Published in Cancer Weekly, November 19th, 2002
Nick M. Spirtos and colleagues at the Women's Cancer Center of Northern California in Palo Alto and other institutions in Buffalo, Miami, and Durham, North Carolina, evaluated the relapse and survival rates for patients who received perioperative blood transfusions.
The use of blood products during surgery had no significant effect on the risk of postoperative mortality or relapse risks, Spirtos and coauthors found.
The researchers examined data...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.